Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

tacedinaline MeSH Supplementary Concept Data 2026


MeSH Supplementary
tacedinaline
Unique ID
C081895
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C081895
Entry Term(s)
4-acetylamino-N-(2'-aminophenyl)benzamide
CI 994
CI-994
GOE 5549
GOE-5549
PD 123654
PD-123654
acetyldinaline
Pharm Action
Antineoplastic Agents
Histone Deacetylase Inhibitors
Registry Numbers
UMF554N5FG
Related Numbers
112522-64-2
Heading Mapped to
*Benzamides
*Phenylenediamines
Frequency
44
Note
oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
Source
Cancer Res 1993 Jul 1;53(13):3008-14
Date Introduced
1993/07/27
Last Updated
2020/05/29
tacedinaline Preferred
CI 994 Narrower
GOE 5549 Narrower
PD 123654 Narrower
page delivered in 0.008s